Brooks Laboratories Limited
Share Price Target & Analysis
NSE:BROOKS
VWAP
Open
Close
High
Low
52 Week High
1.84 (2.88%)
BROOKS
(PHARMA)Turnaround Potential
52 Week Low
EPS
PE
PB
Economical
Quality
Gold
Valuation
#Analysis
NSE: BROOKS Share Price Financial Analysis & Valuation
Brooks Laboratories Limited (BROOKS) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of SME Stocks company with Market Capitalization of Rs 233.2 (in Cr). Total number of free float shares are 1.6 (in Lacs).
Brooks Laboratories Limited is listed on NSE with Exchange ID - INE650L01011 and trading code is NSE:BROOKS with short name Brooks Labs.
In the past 1 year, Brooks Laboratories Limited has declared an equity dividend of Rs 0 per share. At the current share price of BROOKS at Rs 65.69, this results in a dividend yield of 0 %.
As per the Fundamental Analysis of NSE:BROOKS, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine BROOKS underlying value and future prospects. All of this data is available in BROOKS financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:BROOKS, it is clearly understood that BROOKS is Economical performer in terms of earnings and profit margins with an EPS of 2.51. NSE:BROOKS book value per share as of today is 41.51. The current price to book ratio for BROOKS as of Sep 11, 2026 is 1.58.
Valuation of the Stock: The current valuation of BROOKS stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of BROOKS whether to BUY this stock at current valuation. The delivery percentage of BROOKS is 6695% is very crucial parameter which shows that 6695% investors are anticipating that the price of BROOKS share should go up with VWAP at 66.42.
Now, the main question is whether to BUY or SELL, NSE:BROOKS at current valuation.
As per latest Analysis No. #2074:-
⇑ STRONG BUY BROOKS if All Greens
⇗ BUY BROOKS (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD BROOKS (With Stop Loss) if only 1 Green
⇘ SELL BROOKS if NO Green Indicator
NSE: BROOKS Share Price Today (Sep 11, 2026)
(Brooks Laboratories Limited Daily Analysis on the basis of BROOKS Intraday Graph & Trend)
Brooks Laboratories Limited share price moved Up by 2.88% from its previous close of Rs 63.85. BROOKS stock last traded price is 65.69. BROOKS share price trend is Up with a total of 101530 stocks traded till now. It has touched an intraday high of Rs 69.72 and an intraday low of Rs 63.12. The BROOKS trading at 65.69, Up by Rs. 1.84, or 2.88 percent which suggests that most of the Traders are anticipating that the price of BROOKS share should go Up.
NSE: BROOKS Share Price Tomorrow Prediction
(Brooks Laboratories Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of BROOKS)
Brooks Laboratories Limited share price moved Up by 2.88%. BROOKS share price short term trend is Up. It suggests that BROOKS Share Price for Tomorrow remains the same with VWAP at 66.42 will be treated as stop loss for intraday traders. Brooks Laboratories Limited Long term investors can follow the BROOKS long term trend as mentiond in future forecast table.
NSE Code |
NSE: BROOKS |
BROOKS Share Price Today |
65.69 |
BROOKS Share Price Target Prediction for 2026 ^ |
38.1 - 106.7 |
BROOKS Share Price Target Prediction for 2027*^ |
106.7 - 175.5 |
BROOKS Share Price Target Prediction for 2028*^ |
175.5 - 187.8 |
BROOKS Share Price Target Prediction for 2029*^ |
197 |
BROOKS Share Price Target Prediction for 2030*^ |
203 |
BROOKS Share Price Target Prediction for 2035*^ |
221 |
| BROOKS Current Book Value |
41.3 |
*Brooks Laboratories Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^BROOKS share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
BROOKS Technical Analysis
Candlestick Pattern: @62.99| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 64.84 | SELL | 64.49 | SELL |
| MA_12 | 64.92 | SELL | 64.43 | SELL |
| MA_20 | 63.55 | SELL | 64.12 | SELL |
| MA_32 | 62.54 | BUY | 64.06 | SELL |
| MA_50 | 65.09 | SELL | 64.16 | SELL |
| MA_100 | 63.48 | SELL | 65.07 | SELL |
| MA_200 | 68.62 | SELL | 75.11 | SELL |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 63.55 | Downtrend |
| MACD | 0.13 | BUY |
| ADX | 22.75 | NO or Weak Trend |
| DMI (+/-) | 25.04 / 20.53 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 47.43 | Neutral |
| STOCHASTIC_K (Fast) | 19.95 | Oversold |
| STOCHASTIC_D (Slow) | 29.81 | Neutral |
| CCI | -44.26 | Neutral |
| PSAR | 71.2 | SELL |
| TRUE RANGE | 4.35 | Neutral |
| ATR | 3.37 | Neutral |
| WILLIAMS R | -67.82 | Neutral |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 0 | Oversold |
| STOCHASTIC RSI D | 33.33 | Neutral |
| MOMENTUM | 3.48 | BUY |
| Duration | Value |
|---|---|
| 1 Year | -56.72% |
| 3 Months | -7.68% |
| 1 Month | 5.85% |
| 1 Week | -3.24% |
| Action | Overall (%) |
|---|---|
| BUY | 13% |
| NEUTRAL / HOLD | 30% |
| SELL | 57% |
Most popular Questions & Answers about BROOKS (/ FAQ BROOKS)
Brooks Laboratories Limited stock last traded price is 65.69. BROOKS share price moved Up by 2.88% from its previous close of Rs 63.85.
Brooks Laboratories Limited share price trend is Up with a total of 101530 stocks traded till now. It has touched an intraday high of Rs 165.539 and an intraday low of Rs 63.12. The BROOKS trading at 65.69, Up by Rs. 1.84, or 2.88 percent which suggests that most of the Traders are anticipating that the price of BROOKS share should go Up and the Stop Loss will be around 66.42.
The market cap of Brooks Laboratories Limited is ₹233.2 (in Cr) as of Sep 10, 2026.
The current price to earning ratio for Brooks Laboratories Limited as of Sep 10, 2026 is 42.38.
The current price to book ratio for Brooks Laboratories Limited as of Sep 10, 2026 is 1.58.
The highest price of Brooks Laboratories Limited stock is ₹163.9 in the last 52-week.
The lowest price of Brooks Laboratories Limited stock is ₹36.3 in the last 52-week.
Brooks Laboratories Limited share trading at ₹65.69, Up by Rs. 1.84, or 2.88 percent which suggests that most of the traders are anticipating that the price of BROOKS share should go Up.
In 2026, Stock price target for Brooks Laboratories Limited (BROOKS) will be around ₹38.1 on downside and ₹106.7 on upside. Brooks Laboratories Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Brooks Laboratories Limited (BROOKS) will be around ₹106.7 on downside and ₹175.5 on upside. Brooks Laboratories Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Brooks Laboratories Limited (BROOKS) will be around ₹175.5 on downside and ₹187.8 on upside. Brooks Laboratories Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Brooks Laboratories Limited (BROOKS) will be around ₹203 Brooks Laboratories Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of BROOKS.
The price of Brooks Laboratories Limited (BROOKS) shares moved by 2.88%. The short-term trend for BROOKS share price is Up. It implies that the share price of BROOKS will stay the same tomorrow and that intraday traders should treat VWAP at 66.42 as a stop loss. Investors with a long-term outlook can track BROOKS long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of BROOKS stock is 30.1. Compared to the current market price of 65.69 INR, the BROOKS stock is Overvalued by 54.2%.
As per the fundamental analysis of Brooks Laboratories Limited (BROOKS), it is of Economical quality in terms of earnings and profit margins with an EPS of 2.51. Brooks Laboratories Limited book value per share as of today is 41.51. The current price to book ratio for BROOKS as of Sep 11, 2026 is 1.58.
NSE:BROOKS News & Other Useful Information about BROOKS Share Price
Peer Comparison of NSE: BROOKS
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1840.00 | 16.35 | 97.89 |
| DIVISLAB | 9322.00 | 115.55 | 663.06 |
| MEDICAMEQ | 323.05 | 12.15 | 208.08 |
| CIPLA | 1366.00 | 51.67 | 434.03 |
| DRREDDY | 1165.50 | 53.19 | 380.63 |
| TORNTPHARM | 4965.50 | 87.32 | 235.7 |
| BIOCON | 390.65 | 1.27 | 166.51 |
| LUPIN | 2095.00 | 154.86 | 718.37 |
| ALKEM | 5087.50 | 212.33 | 1218.48 |
| AUROPHARMA | 1679.80 | 46.49 | 403.84 |
| ABBOTINDIA | 25550.00 | 766.11 | 2448.41 |
| GLAXO | 2828.40 | 63.65 | 147.25 |
| IPCALAB | 1968.50 | 56.72 | 329.23 |
| LAURUSLABS | 1969.00 | 20.74 | 102.57 |
| LALPATHLAB | 1909.00 | 39.68 | 157.23 |
| PFIZER | 4060.20 | 170.54 | 963.41 |
| AJANTPHARM | 3533.40 | 89.3 | 363.23 |
| SANOFI | 3079.20 | 158.05 | 332.96 |
| NATCOPHARM | 815.35 | 82.14 | 481.67 |
| APLLTD | 810.95 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2419.20 | 1.24 | 881.78 |
| AAREYDRUGS | 98.89 | 2.39 | 53.38 |
| JUBLPHARMA | 1025.20 | 4.35 | 145.63 |
| SPARC | 196.01 | 48.14 | 40.45 |
| GRANULES | 909.30 | 23.25 | 180.42 |
| ASTRAZEN | 6764.50 | 86.44 | 364.29 |
| CAPLIPOINT | 2754.90 | 55.52 | 285.6 |
| FDC | 341.45 | 21.19 | 161.21 |
| HIKAL | 224.95 | 9.34 | 96.63 |